PP_1170x120_10-25-21

Aurobindo Pharma

Aurobindo cleared to market Tambocor generic

DAYTON, N.J. — Aurobindo Pharma Ltd. has received final approval from the U.S. Food and Drug Administration for flecainide acetate tablets, a medication for irregular heartbeat. Aurobindo said its product — available in dosages of 50 mg, 100 mg and 150 mg — is a generic equivalent of Tambocor tablets from Medicis (now part of

Aurobindo launches generic of Suprax

DAYTON, N.J. — Aurobindo Pharma Ltd. has received the first Abbreviated New Drug Application approval from the Food and Drug Administration for cefixime for oral suspension, USP, 100 mg/5 ml and 200 mg/5 ml. Cefixime for O.S. is bioequivalent and therapeutically equivalent to Suprax from Lupin Pharmaceuticals Inc. It is indicated for the treatment of